Public information on shortages in the EU/EEA: improvements made between 2018 and 2020.

Background: In July 2019, the Heads of Medicines Agencies/European Medicines Agency (HMA/EMA) Task Force on Availability of Authorised Medicines for Human and Veterinary Use (TFAAM) published good practice guidance which provides key principles for European Union (EU) regulatory authorities for communication on shortages and availability issues. The use of a shortage catalogue was a key recommendation.

Objectives: To assess how EU/European Economic Area (EEA) national competent authorities have implemented the recommendations of the good practice guidance.